New animal models to study the role of tyrosinase in normal retinal development

Frontiers in Bioscience

Volumn 11, Issue 1 P.447-888, 2006, Pages 743-752

  Lavado, Alfonso ^a,b   Montoliu, Lluis ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Albinism; L DOPA; Melanin; Optic Quiasm; Retinal Pigment Epithelium; Review; Transgenic Mice

Indexed keywords

ANIMALIA; MUS MUSCULUS;

EID: 32944475149     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1832     Document Type: Review

References (100)

1. Giraldo P & L. Montoliu: Size matters: use of YACs, BACs and PACs in transgenic animals. Transgenic Res 10, 83-103 (2001)
2. Passeron T, F. Mantoux & J. P. Ortonne: Genetic disorders of pigmentation. Clin Dermatol 23, 56-67 (2005)
3. Jackson I. J, P. Budd, J. M. Horn, R. Johnson, S. Raymond & K. Steel: Genetics and molecular biology of mouse pigmentation. Pigment Cell Res 7, 73-80 (1994)
4. Jackson I. J: Molecular and developmental genetics of mouse coat color. Annu Rev Genet 28, 189-217 (1994)
5. Barsh G. S: The genetics of pigmentation: from fancy genes to complex traits. Trends Genet 12, 299-305 (1996)
6. Nakamura M., D. J. Tobin, B. Richards-Smith, J. P. Sundberg & R. Paus: Mutant laboratory mice with abnormalities in pigmentation: annotated tables. J Dermatol Sci 28, 1-33 (2002)
7. Bennett D. C & M. L. Lamoreux: The color loci of mice-a genetic century. Pigment Cell Res 16, 333-344 (2003)
8. Kelsh R. N: Genetics and evolution of pigment patterns in fish. Pigment Cell Res 17, 326-336 (2004).
9. Neuhauss S. C., O. Biehlmaier, M. W. Seeliger, T. Das, K. Kohler, W. A. Harris & H. Baier: Genetic disorders of vision revealed by a behavioral screen of 400 essential loci in zebrafish. J Neurosci 19, 8603-8615 (1999)
10. Kinnear P. E, B. Jay & C. J. Jr. Witkop: Albinism. Surv Ophthalmol 30, 75-101 (1985)
11. Oetting W. S: Albinism. Curr Opin Pediatr 11, 565-571 (1999)
12. Russell-Eggitt I: Albinism. Ophthalmol Clin North Am 14, 533-546 (2001)
13. Elschnig A: Zur Anatomie des menschlichen Albino-Auges. Graefes Arch Ophthalmol 84, 401-419 (1913)
14. Guillery R. W: Neurobiology. Routes for development. Nature 323, 394-395 (1986)
15. Jeffery G: The albino retina: an abnormality that provides insight into normal retinal development. Trends Neurosci 20, 165-169 (1997)
16. Jeffery G: The relationship between cell density and the nasotemporal division in the rat retina. Brain Res 347, 354-357 (1985)
17. Stone J., M. H. Rowe & J. E. Campion: Retinal abnormalities in the Siamese cat. J Comp Neurol 180, 773-782 (1978)
18. Jeffery G., K. Darling & A. Whitmore: Melanin and the regulation of mammalian photoreceptor topography. Eur J Neurosci 6, 657-667 (1994)
19. Ilia M. & G. Jeffery: Retinal cell addition and rod production depend on early stages of ocular melanin synthesis. J Comp Neurol 420, 437-444 (2000)
20. Jeffery G: Architecture of the optic chiasm and the mechanisms that sculpt its development. Physiol Rev 81, 1393-1414 (2001)
21. Lund R. D: Uncrossed visual pathways of hooded albino rats. Science 146, 1506-1507 (1965)
22. Giolli R. A & M. D. Guthrie: The primary optic projections in the rabbit - an experimental degeneration study. J Comp Neurol 136, 99-126 (1969)
23. Guillery R. W: An abnormal retinogeniculate projection in Siamese cats. Brain Res 14, 739-741 (1969)
24. Guillery R. W: An abnormal retinogeniculate projection in the albino ferret (Mustela furo). Brain Res 33, 482-485 (1971)
25. Neveu M. M., G. Jeffery, L. C. Burton, J. J. Sloper, G. E. Holder: Age-related changes in the dynamics of human albino visual pathways. Eur J Neurosci 18, 1939-1949 (2003)
26. Ilia M. & G. Jeffery: Delayed neurogenesis in the albino retina: evidence of a role for melanin in regulating the pace of cell generation. Brain Res Dev Brain Res 95, 176-183 (1996)
27. Ilia M. & G. Jeffery: Retinal mitosis is regulated by dopa, a melanin precursor that may influence the time at which cells exit the cell cycle: analysis of patterns of cell production in pigmented and albino retinae. J Comp Neurol 405, 394-405 (1999)
28. Rachel R. A., G. Dolen, N. L. Hayes, A. Lu, L. Erskine, R. S. Nowakowski & C. A. Mason: Spatiotemporal features of early neuronogenesis differ in wild-type and albino mouse retina. J Neurosci 22, 4249-4263 (2002)
29. Gimenez E, A. Lavado, G. Jeffery & L. Montoliu: Variegated expression and delayed retinal pigmentation during development in transgenic mice with a deletion in the locus control region of the tyrosinase gene. Genesis 30, 21-25 (2001)
30. Russell L. B, C. S. Montgomery & G. C. Raymer: Analysis of the albino-locus region of the mouse: IV. Characterization of 34 deficiencies. Genetics 100, 427-53 (1982)
31. Kwon B. S, A. K. Haq, S. H. Pomerantz & R. Halaban: Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus. Proc Natl Acad Sci U S A 84, 7473-7477 (1987)
32. Oetting W. S, J. P. Fryer, S. Shriram & R. A. King: Oculocutaneous albinism type 1: the last 100 years. Pigment Cell Res 16, 307-311 (2003)
33. Oetting W. S & R. A. King. Molecular basis of albinism: mutations and polymorphisms of pigmentation genes associated with albinism. Hum Mutat 13, 99-115 (1999)
34. King R. A, J. Pietsch, J. P. Fryer, S. Savage, M. J. Brott, I. Russell-Eggitt, C. G. Summers & W. S. Oetting: Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype. Hum Genet 113, 502-13 (2003)
35. Jackson I. J & D. C. Bennett: Identification of the albino mutation of mouse tyrosinase by analysis of an in vitro revertant. Proc Natl Acad Sci U S A 87, 7010-7014 (1990)
36. Yokoyama T, D. W. Silversides, K. G. Waymire, B. S. Kwon, T. Takeuchi & P. A. Overbeek: Conserved cysteine to serine mutation in tyrosinase is responsible for the classical albino mutation in laboratory mice. Nucleic Acids Res 18, 7293-7298 (1990)
37. Shibahara S., S. Okinaga, Y. Tomita, A. Takeda, H. Yamamoto, M. Sato & T. Takeuchi: A point mutation in the tyrosinase gene of BALB/c albino mouse causing the cysteine-serine substitution at position 85. Eur J Biochem 189, 455-461 (1990)
38. Nadeau J. H: Modifier genes in mice and humans. Nat Rev Genet 2, 165-174 (2001)
39. Toyofuku K, I. Wada, J. C. Valencia, T. Kushimoto, V. J. Ferrans & V. J. Hearing: Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins. FASEB J 15, 2149-2161 (2001)
40. Lavado A, C. Olivares, J. C. Garcia-Borron & L. Montoliu: Molecular basis of the extreme dilution mottled mouse mutation. A combination of coding and non-coding genomic alterations. J Biol Chem 280, 4817-4824 (2005)
41. Dräger U. C: Autoradiography of tritiated proline and fucose transported transneuronally from the eye to the visual cortex in pigmented and albino mice. Brain Res 27, 284-292 (1974)
42. Creel D & R. A. Giolli: Retinogeniculate projections in albino and ocularly hypopigmented rats. J Comp Neurol 166, 445-455 (1976)
43. Wise R. P & R. D. Lund: The retina and central projections of heterochromic rats. Exp Neurol 51, 68-77 (1976)
44. Beermann F, E. Schmid & G. Schutz: Expression of the mouse tyrosinase gene during embryonic development: recapitulation of the temporal regulation in transgenic mice. Proc Natl Acad Sci U S A 89, 2809-2813 (1992)
45. Gimenez E, A. Lavado, P. Giraldo & L. Montoliu: Tyrosinase expression is not detected in mouse brain outside the retinal pigment epithelium cells. Eur J Neurosci 18, 2673-2676 (2003)
46. Beermann F, S. Ruppert, E. Hummler, F. X. Bosch, G. Muller, U. Ruther & G. Schutz: Rescue of the albino phenotype by introduction of a functional tyrosinase gene into mice. EMBO J 9, 2819-2826 (1990)
47. Overbeek P. A, E. Aguilar-Cordova, G. Hanten, D. L. Schaffner, P. Patel, R. M. Lebovitz & M. W. Lieberman: Coinjection strategy for visual identification of transgenic mice. Transgenic Res 1, 31-37 (1991)
48. Tanaka S, H. Yamamoto, S. Takeuchi & T. Takeuchi: Melanization in albino mice transformed by introducing cloned mouse tyrosinase gene. Development 108, 223-227 (1990)
49. Schedl A, L. Montoliu, G. Kelsey & G. Schutz: A yeast artificial chromosome covering the tyrosinase gene confers copy number-dependent expression in transgenic mice. Nature 362, 258-261 (1993)
50. Brem G, U. Besenfelder, B. Aigner, M. Muller, I. Liebl, G. Schutz & L. Montoliu: YAC transgenesis in farm animals: rescue of albinism in rabbits. Mol Reprod Dev 44, 56-62 (1996)
51. Giraldo P & L. Montoliu: Artificial chromosome transgenesis in pigmentary research. Pigment Cell Res 15, 258-264 (2002)
52. Montoliu L, A. Schedl, G. Kelsey, P. Lichter, Z. Larin, H. Lehrach & G. Schutz: Generation of transgenic mice with yeast artificial chromosomes. Cold Spring Harb Symp Quant Biol 58, 55-62 (1993)
53. Jeffery G, G. Brem & L. Montoliu: Correction of retinal abnormalities found in albinism by introduction of a functional tyrosinase gene in transgenic mice and rabbits. Brain Res Dev Brain Res 99, 95-102 (1997)
54. Jeffery G, G. Schutz & L. Montoliu: Correction of abnormal retinal pathways found with albinism by introduction of a functional tyrosinase gene in transgenic mice. Dev Biol 166, 460-464 (1994)
55. Costin G. E, J. C. Valencia, W. D. Vieira, M. L. Lamoreux & V. J. Hearing: Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4. J Cell Sci 116, 3203-3212 (2003)
56. Chen K, P. Manga & S. J. Orlow: Pink-eyed dilution protein controls the processing of tyrosinase. Mol Biol Cell 13, 1953-1964 (2002)
57. Toyofuku K, J. C. Valencia, T. Kushimoto, G. E. Costin, V. M. Virador, W. D. Vieira, V. J. Ferrans & V. J. Hearing: The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase. Pigment Cell Res 15, 217-224 (2002)
58. Rachel R. A, C. A. Mason & F. Beermann: Influence of tyrosinase levels on pigment accumulation in the retinal pigment epithelium and on the uncrossed retinal projection. Pigment Cell Res 15, 273-281 (2002)
59. Donatien P & G. Jeffery: Correlation between rod photoreceptor numbers and levels of ocular pigmentation. Invest Ophthalmol Vis Sci 43, 1198-1203 (2002)
60. Donatien P, B. Aigner & G. Jeffery: Variations in cell density in the ganglion cell layer of the retina as a function of ocular pigmentation. Eur J Neurosci 15, 1597-1602 (2002)
61. Gimenez E, A. Lavado, P. Giraldo, P. Cozar, G. Jeffery & L. Montoliu: A transgenic mouse model with inducible tyrosinase gene expresión using the tetracycline (Tet-on) system allows regulated rescue of abnormal chiasmatic projections found in albinism. Pigment Cell Res 17, 363-370 (2004)
62. Cronin C. A, W. Gluba & H. Scrable: The lac operator-repressor system is functional in the mouse. Genes Dev 15, 1506-1517 (2001)
63. Kistner A, M. Gossen, F. Zimmermann, J. Jerecic, C. Ulmer, H. Lubbert & H. Bujard: Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci U S A 93, 10933-10938 (1993)
64. Shin M. K: Controlling gene expression in mice with tetracycline: application in pigment cell research. Pigment Cell Res 13, 326-331 (2000)
65. Ryding A. D, M. G. Sharp & J. J. Mullins: Conditional transgenic technologies J Endocrinol 171, 1-14 (2001)
66. Goding C. R: Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. Genes Dev 14, 1712-1728 (2000)
67. Mills A. A: Changing colors in mice: an inducible system that delivers. Genes Dev 15, 1461-1467 (2001)
68. Hu M. C. & N. Davidson: The inducible lac operator-repressor system is functional in mammalian cells. Cell 48, 555-566 (1987)
69. Wyborski D. L., L. C. DuCoeur & J. M. Short: Parameters affecting the use of the lac repressor system in eukaryotic cells and transgenic animals. Environ Mol Mutagen 28, 447-458 (1996)
70. Scrable H. & P. J.Stambrook: Activation of the lac repressor in the transgenic mouse. Genetics 147, 297-304 (1997)
71. Cronin C. A, A. B. Ryan, E. M. Talley & H. Scrable: Tyrosinase expression during neuroblast divisions affects later pathfinding by retinal ganglion cells J Neurosci 23, 11692-11697 (2003)
72. Yueh Y. G., P. J. Yaworsky & C. Kappen: Herpes simplex virus transcriptional activator VP16 is detrimental to preimplantation development in mice. Mol Reprod Dev 55, 37-46 (2000)
73. Scrable H.: Say when: reversible control of gene expression in the mouse by lac. Semin Cell Dev Biol 13, 109-119 (2002)
74. Ryan A. & H. Scrable: Visualization of the dynamics of gene expression in the living mouse. Mol Imaging 3, 33-42 (2004)
75. Gingrich J. R. & J. Roder: Inducible gene expression in the nervous system of transgenic mice. Annu Rev Neurosci 21, 377-105 (1998)
76. Lewandoski M.: Conditional control of gene expression in the mouse. Nat Rev Genet 2, 743-55 (2001)
77. Mansuy I. M. & H. Bujard: Tetracycline-regulated gene expression in the brain. Curr Opin Neurobiol 10, 593-596 (2000)
78. Wells K. D., J. A. Foster, K. Moore, V. G. Pursei & R. J. Wall: Codon optimization, genetic insulation, and an rtTA reporter improve performance of the tetracycline switch. Transgenic Res 8, 371-381 (1999)
79. Yamamoto A., R. Hen & W. T. Dauer: The ons and offs of inducible transgenic technology: a review. Neurobiol Dis 8, 923-932 (2001)
80. Urlinger S., U. Baron, M. Thellmann, M. T. Hasan, H. Bujard, W. Hillen: Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci U S A. 97, 7963-7968 (2000)
81. Kluppel M, F. Beermann, S. Ruppert, E. Schmid, E. Hummler & G. Schutz: The mouse tyrosinase promoter is sufficient for expression in melanocytes and in the pigmented epithelium of the retina. Proc Natl Acad Sci U S A 88, 3777-3781 (1991)
82. Ganss R, G. Schutz & F. Beermann: The mouse tyrosinase gene. Promoter modulation by positive and negative regulatory elements. J Biol Chem 269, 29808-29816 (1994)
83. Horsford D. J, M. T. Nguyen, G. C. Sellar, R. Kothary, H. Arnheiter & R. R. McInnes: Chx10 repression of Mitf is required for the maintenance of mammalian neuroretinal identity. Development 132, 177-187 (2005)
84. Ganss R, L. Montoliu, A. P. Monaghan & G. Schutz: A cell-specific enhancer far upstream of the mouse tyrosinase gene confers high level and copy number-related expression in transgenic mice. EMBO J 13, 3083-3093 (1994)
85. Montoliu L, T. Umland & G. Schutz: A locus control region at -12 kb of the tyrosinase gene. EMBO J 15, 6026-6034 (1996)
86. Porter S. D & C. J. Meyer: A distal tyrosinase upstream element stimulates gene expression in neural-crest-derived melanocytes of transgenic mice: position-independent and mosaic expression. Development 120, 2103-2111 (1994)
87. Camacho-Hubner A & F. Beermann: Increased transgene expression by the mouse tyrosinase enhancer is restricted to neural crest-derived pigment cells. Genesis 29, 180-187 (2001)
88. Giraldo P, A. Martinez, L. Regales, A. Lavado, A. Garcia-Diaz, A. Alonso, A. Busturia & L. Montoliu: Functional dissection of the mouse tyrosinase locus control region identifies a new putative boundary activity. Nucleic Acids Res 31, 6290-6305 (2003)
89. Porter S. D, J. Hu & C. B. Gilks: Distal upstream tyrosinase S/MAR-containing sequence has regulatory properties specific to subsets of melanocytes. Dev Genet 25, 40-48 (1999)
90. Festenstein R, M. Tolaini, P. Corbella, C. Mamalaki, J. Parrington, M. Fox, A. Miliou, M. Jones & D. Kioussis: Locus control region function and heterochromatin-induced position effect variegation. Science 271, 1123-1125 (1996)
91. Sutherland H. G, D. I. Martin & E. Whitelaw: A globin enhancer acts by increasing the proportion of erythrocytes expressing a linked transgene. Mol Cell Biol 17, 1607-1614 (1997)
92. Gimenez E, A. Lavado, G. Jeffery & L Montoliu: Regional abnormalities in retinal development are associated with local ocular hypopigmentation. J Comp Neurol 485, 338-347 (2005)
93. Young R. W: The ninth Frederick H. Verhoeff lecture. The life history of retinal cells. Trans Am Ophthalmol Soc 81, 193-228 (1983)
94. Hayes B. P: The distribution of intercellular gap junctions in the developing retina and pigment epithelium of Xenopus laevis. Anat Embryol (Berl) 150, 99-111 (1976)
95. Drager U. C.: Birth dates of retinal ganglion cells giving rise to the crossed and uncrossed optic projections in the mouse. Proc R Soc Lond B Biol Sci 224, 57-77 (1985)
96. Akeo K., Tanaka Y. & S. Okisaka: A comparison between melanotic and amelanotic retinal pigment epithelial cells in vitro concerning the effects of L-dopa and oxygen on cell cycle. Pigment Cell Res 7, 145-151 (1994)
97. Libby R. T, R. S. Smith, O. V. Savinova, A. Zabaleta, J. E. Martin, F. J. Gonzalez & S. W. John: Modification of ocular defects in mouse developmental glaucoma models by tyrosinase. Science 299, 1578-1581 (2003)
98. Kobayashi K, S. Morita, H. Sawada, T. Mizuguchi, K. Yamada, I. Nagatsu, T. Hata, Y. Watanabe, K. Fujita & T. Nagatsu: Targeted disruption of the tyrosine hydroxylase locus results in severe catecholamine depletion and perinatal lethality in mice. J Biol Chem. 270, 27235-27243 (1995)
99. Rios M, B. Habecker, T. Sasaoka, G. Eisenhofer, H. Tian, S. Landis, D. Chikaraishi & S. Roffler-Tarlov: Catecholamine synthesis is mediated by tyrosinase in the absence of tyrosine hydroxylase. J Neurosci 19, 3519-3526 (1999)
100. Eisenhofer G, H. Tian, C. Holmes, J. Matsunaga, S. Roffler-Tarlov & V. J. Hearing: Tyrosinase: a developmentally specific major determinant of peripheral dopamine. FASEB J 17, 1248-1255 (2003)